Binding Global AI & Biorisk Governance Pact
A multilateral, legally binding agreement on frontier AI development or biological risk is ratified and implemented by the United States, China, the EU, and at least two other major powers — not a declaration of principles, but a treaty with enforcement mechanisms.
- Median year
- 2036
- P10 – P90 range
- 2030 – 2050
- Probability ever occurs
- 55%
- Last reviewed
- June 2026
The major powers reach and implement a binding agreement on the most dangerous AI or biological capabilities. The precedent represents the first successful extension of arms-control-style governance to transformative technologies.
The coordination problem proves too hard. National AI and biotech programs proceed under voluntary frameworks and competing regulatory regimes. Governance lags capability by years.
Where things stand
The WEF 2026 data is striking: only 6% of experts expect revived multilateralism over the next decade. That single data point argues for placing this event later and lower-probability than instinct suggests. The current trajectory is toward competing national AI strategies, fragmented export controls, and voluntary industry commitments — not binding multilateral governance.
What exists in 2026:
- The AI Safety Summit process (Bletchley Park 2023, Seoul 2024) established a dialogue forum but no binding commitments
- The EU AI Act is regional, not global
- Biosecurity governance (Biological Weapons Convention) lacks verification mechanisms, and no AI-equivalent has been negotiated
The deep challenge: unlike nuclear weapons — where the technology was state-controlled and visible — frontier AI and synthetic biology are embedded in commercial R&D, making verification and attribution difficult. The historical precedent of Chemical Weapons Convention verification is useful but not directly applicable.